Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2
2(50.0%)
Early Phase 1
1(25.0%)
Phase 4
1(25.0%)
4Total
Phase 2(2)
Early Phase 1(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT00178659Active Not Recruiting

Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)

Role: collaborator

NCT04055623Phase 2Unknown

T-regulatory Cells in ALS

Role: collaborator

NCT02104739Phase 4Completed

Effects of Antidiabetic Medications on the Postprandial State in Prediabetes

Role: collaborator

NCT01060995Completed

SmartConsent: A Computerized Informed Consent for Patients

Role: collaborator

NCT01286402Phase 2Completed

Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy

Role: collaborator

NCT00901706Early Phase 1Completed

Multidimensional Assessment and Intervention for Elder Self-Neglect

Role: collaborator

All 6 trials loaded